Boundary layer infusion of basic fibroblast growth factor accelerates intimal hyperplasia in endarterectomized canine artery

Changyi Chen, Juan Li, Samer Mattar, Glenn F. Pierce, Lea Aukerman, Stephen R. Hanson, Alan B. Lumsden

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

We examined the effects of human recombinant basic fibroblast growth factor (bFGF) on the proliferation and migration of cultured dog smooth muscle cells (SMCs) and endothelial cells (ECs) and the effect of continuous local boundary layer infusion of bFGF on intimal hyperplasia in endarterectomized dog artery. In vitro proliferation and migration of dog SMCs or ECs were performed using direct counting and Boyden's chamber, respectively. At a dose of 10 ng/mL, bFGF significantly promoted both SMC and EC proliferation (7-and 4-fold, respectively) and migration (2.3-and 1.9- fold, respectively). Six dogs underwent bilateral carotid endarterectomies. A newly designed local infusion device with an osmotic pump continuously delivered bFGF to one artery or vehicle solution to the contralateral artery for 14 days. The intimal thickness and area in the bFGF-treated vessels were increased by 72 and 81%, respectively, compared with control arteries (P <0.05). As assessed by the bromodeoxyuridine index, the proliferative activity was increased by 73% in bFGF-treated arteries (P = 0.03). Furthermore, cell proliferation at the distal anastomoses of local in fusion device was significantly increased in the bFGF- infused grafts compared with distal anastomoses in the control grafts (13.24 ± 1.24% versus 5.24 ± 1.01%, P 0.01). These data demonstrate that human recombinant bFGF has a potent effect on dog SMC and EC proliferation and migration, and that local infusion of exogenous bFGF significantly enhances the intimal hyperplasia formation and cell proliferation to vascular injury. We conclude that the bFGF pathway may contribute to the development of intimal hyperplastic lesions.

Original languageEnglish (US)
Pages (from-to)300-306
Number of pages7
JournalJournal of Surgical Research
Volume69
Issue number2
DOIs
StatePublished - May 1997
Externally publishedYes

Fingerprint

Tunica Intima
Fibroblast Growth Factor 2
Hyperplasia
Canidae
Arteries
Smooth Muscle Myocytes
Dogs
Endothelial Cells
Cell Proliferation
Transplants
Equipment and Supplies
Carotid Endarterectomy
Vascular System Injuries
Bromodeoxyuridine
Cell Movement

ASJC Scopus subject areas

  • Surgery

Cite this

Boundary layer infusion of basic fibroblast growth factor accelerates intimal hyperplasia in endarterectomized canine artery. / Chen, Changyi; Li, Juan; Mattar, Samer; Pierce, Glenn F.; Aukerman, Lea; Hanson, Stephen R.; Lumsden, Alan B.

In: Journal of Surgical Research, Vol. 69, No. 2, 05.1997, p. 300-306.

Research output: Contribution to journalArticle

Chen, Changyi ; Li, Juan ; Mattar, Samer ; Pierce, Glenn F. ; Aukerman, Lea ; Hanson, Stephen R. ; Lumsden, Alan B. / Boundary layer infusion of basic fibroblast growth factor accelerates intimal hyperplasia in endarterectomized canine artery. In: Journal of Surgical Research. 1997 ; Vol. 69, No. 2. pp. 300-306.
@article{843d692883b444a2a9d7bb6504a4dcd9,
title = "Boundary layer infusion of basic fibroblast growth factor accelerates intimal hyperplasia in endarterectomized canine artery",
abstract = "We examined the effects of human recombinant basic fibroblast growth factor (bFGF) on the proliferation and migration of cultured dog smooth muscle cells (SMCs) and endothelial cells (ECs) and the effect of continuous local boundary layer infusion of bFGF on intimal hyperplasia in endarterectomized dog artery. In vitro proliferation and migration of dog SMCs or ECs were performed using direct counting and Boyden's chamber, respectively. At a dose of 10 ng/mL, bFGF significantly promoted both SMC and EC proliferation (7-and 4-fold, respectively) and migration (2.3-and 1.9- fold, respectively). Six dogs underwent bilateral carotid endarterectomies. A newly designed local infusion device with an osmotic pump continuously delivered bFGF to one artery or vehicle solution to the contralateral artery for 14 days. The intimal thickness and area in the bFGF-treated vessels were increased by 72 and 81{\%}, respectively, compared with control arteries (P <0.05). As assessed by the bromodeoxyuridine index, the proliferative activity was increased by 73{\%} in bFGF-treated arteries (P = 0.03). Furthermore, cell proliferation at the distal anastomoses of local in fusion device was significantly increased in the bFGF- infused grafts compared with distal anastomoses in the control grafts (13.24 ± 1.24{\%} versus 5.24 ± 1.01{\%}, P 0.01). These data demonstrate that human recombinant bFGF has a potent effect on dog SMC and EC proliferation and migration, and that local infusion of exogenous bFGF significantly enhances the intimal hyperplasia formation and cell proliferation to vascular injury. We conclude that the bFGF pathway may contribute to the development of intimal hyperplastic lesions.",
author = "Changyi Chen and Juan Li and Samer Mattar and Pierce, {Glenn F.} and Lea Aukerman and Hanson, {Stephen R.} and Lumsden, {Alan B.}",
year = "1997",
month = "5",
doi = "10.1006/jsre.1997.5052",
language = "English (US)",
volume = "69",
pages = "300--306",
journal = "Journal of Surgical Research",
issn = "0022-4804",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Boundary layer infusion of basic fibroblast growth factor accelerates intimal hyperplasia in endarterectomized canine artery

AU - Chen, Changyi

AU - Li, Juan

AU - Mattar, Samer

AU - Pierce, Glenn F.

AU - Aukerman, Lea

AU - Hanson, Stephen R.

AU - Lumsden, Alan B.

PY - 1997/5

Y1 - 1997/5

N2 - We examined the effects of human recombinant basic fibroblast growth factor (bFGF) on the proliferation and migration of cultured dog smooth muscle cells (SMCs) and endothelial cells (ECs) and the effect of continuous local boundary layer infusion of bFGF on intimal hyperplasia in endarterectomized dog artery. In vitro proliferation and migration of dog SMCs or ECs were performed using direct counting and Boyden's chamber, respectively. At a dose of 10 ng/mL, bFGF significantly promoted both SMC and EC proliferation (7-and 4-fold, respectively) and migration (2.3-and 1.9- fold, respectively). Six dogs underwent bilateral carotid endarterectomies. A newly designed local infusion device with an osmotic pump continuously delivered bFGF to one artery or vehicle solution to the contralateral artery for 14 days. The intimal thickness and area in the bFGF-treated vessels were increased by 72 and 81%, respectively, compared with control arteries (P <0.05). As assessed by the bromodeoxyuridine index, the proliferative activity was increased by 73% in bFGF-treated arteries (P = 0.03). Furthermore, cell proliferation at the distal anastomoses of local in fusion device was significantly increased in the bFGF- infused grafts compared with distal anastomoses in the control grafts (13.24 ± 1.24% versus 5.24 ± 1.01%, P 0.01). These data demonstrate that human recombinant bFGF has a potent effect on dog SMC and EC proliferation and migration, and that local infusion of exogenous bFGF significantly enhances the intimal hyperplasia formation and cell proliferation to vascular injury. We conclude that the bFGF pathway may contribute to the development of intimal hyperplastic lesions.

AB - We examined the effects of human recombinant basic fibroblast growth factor (bFGF) on the proliferation and migration of cultured dog smooth muscle cells (SMCs) and endothelial cells (ECs) and the effect of continuous local boundary layer infusion of bFGF on intimal hyperplasia in endarterectomized dog artery. In vitro proliferation and migration of dog SMCs or ECs were performed using direct counting and Boyden's chamber, respectively. At a dose of 10 ng/mL, bFGF significantly promoted both SMC and EC proliferation (7-and 4-fold, respectively) and migration (2.3-and 1.9- fold, respectively). Six dogs underwent bilateral carotid endarterectomies. A newly designed local infusion device with an osmotic pump continuously delivered bFGF to one artery or vehicle solution to the contralateral artery for 14 days. The intimal thickness and area in the bFGF-treated vessels were increased by 72 and 81%, respectively, compared with control arteries (P <0.05). As assessed by the bromodeoxyuridine index, the proliferative activity was increased by 73% in bFGF-treated arteries (P = 0.03). Furthermore, cell proliferation at the distal anastomoses of local in fusion device was significantly increased in the bFGF- infused grafts compared with distal anastomoses in the control grafts (13.24 ± 1.24% versus 5.24 ± 1.01%, P 0.01). These data demonstrate that human recombinant bFGF has a potent effect on dog SMC and EC proliferation and migration, and that local infusion of exogenous bFGF significantly enhances the intimal hyperplasia formation and cell proliferation to vascular injury. We conclude that the bFGF pathway may contribute to the development of intimal hyperplastic lesions.

UR - http://www.scopus.com/inward/record.url?scp=0031147695&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031147695&partnerID=8YFLogxK

U2 - 10.1006/jsre.1997.5052

DO - 10.1006/jsre.1997.5052

M3 - Article

VL - 69

SP - 300

EP - 306

JO - Journal of Surgical Research

JF - Journal of Surgical Research

SN - 0022-4804

IS - 2

ER -